Corteva, Inc. against DSM-Firmenich AG — live side-by-side technical comparison.
Prices as of 2026-10-09T20:03:06+00:00 UTC · updates daily
DSFIR.AS leads 4 of the 5 windows we measure — over 1 month CTVA is +4.1% and DSFIR.AS +10.5%; over year to date CTVA is +31.6% and DSFIR.AS +46.4%.
| CTVA | DSFIR.AS | |
|---|---|---|
| Price | $13.24 | $100.65 |
| 1 day | -3.7% | +2.8%lead |
| 5 days | +11.1%lead | +4.7% |
| 1 month | +4.1% | +10.5%lead |
| 6 months | +5.6% | +62.5%lead |
| Year to date | +31.6% | +46.4%lead |
| 52-week position | 75% of range | 100% of range |
| 52-week range | $9.08–$14.62 | $55.22–$100.75 |
| vs 50-day average | above $12.27 | above $93.77 |
| vs 200-day average | above $11.92 | above $75.10 |
| RSI (14) | 62 | 66 |
| Next earnings | 2026-11-11 | 2026-07-30 |
CTVA trades at $13.24, above its 50-day average of $12.27, and above the 200-day at $11.92. It sits at 75% of its 52-week range ($9.08–$14.62); 14-day RSI is 62, in neutral territory; an average session moves it about 262.3%. For levels, the first level overhead is $14.00 (5.7% away) and the first support below is $13.00 (1.8% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
DSFIR.AS trades at $100.65, above its 50-day average of $93.77, and above the 200-day at $75.10. It sits at 100% of its 52-week range ($55.22–$100.75); 14-day RSI is 66, in neutral territory; an average session moves it about 2.2%. For levels, the first level overhead is $125.00 (24.2% away) and the first support below is $100.00 (0.7% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
CTVA is the more volatile of the two — an average session moves it 262.3% against 2.2% for DSFIR.AS, so an identical position size carries roughly 119.2× the daily risk.
The comparison turns on those levels: CTVA clearing $14.00 or losing $13.00; DSFIR.AS clearing $125.00 or losing $100.00. Until one of them gives way, the relative reading above stands.